A practical methodology to improve the dosimetric accuracy of MR-based radiotherapy simulation for brain tumors

Jeffrey C F Lui; Annie M Tang; C C Law; Jonan C Y Lee; Francis K H Lee; Jeffrey Chiu; Kam-Hung Wong

doi:10.1016/j.ejmp.2021.10.008

A practical methodology to improve the dosimetric accuracy of MR-based radiotherapy simulation for brain tumors

Phys Med. 2021 Nov:91:1-12. doi: 10.1016/j.ejmp.2021.10.008. Epub 2021 Oct 19.

Authors

Jeffrey C F Lui¹, Annie M Tang², C C Law², Jonan C Y Lee³, Francis K H Lee², Jeffrey Chiu³, Kam-Hung Wong²

Affiliations

¹ Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong. Electronic address: lcf767@ha.org.hk.
² Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.
³ Department of Radiology, Queen Elizabeth Hospital, Hong Kong.

PMID: 34678686
DOI: 10.1016/j.ejmp.2021.10.008

Abstract

Purpose: To investigate the dosimetric accuracy of synthetic computed tomography (sCT) images generated by a clinically-ready voxel-based MRI simulation package, and to develop a simple and feasible method to improve the accuracy.

Methods: 20 patients with brain tumor were selected to undergo CT and MRI simulation. sCT images were generated by a clinical MRI simulation package. The discrepancy between planning CT and sCT in CT number and body contour were evaluated. To resolve the discrepancies, an sCT specific CT-relative electron density (RED) calibration curve was used, and a layer of pseudo-skin was created on the sCT. The dosimetric impact of these discrepancies, and the improvement brought about by the modifications, were evaluated by a planning study. Volumetric modulated arc therapy (VMAT) treatment plans for each patient were created and optimized on the planning CT, which were then transferred to the original sCT and the modified-sCT for dose re-calculation. Dosimetric comparisons and gamma analysis between the calculated doses in different images were performed.

Results: The average gamma passing rate with 1%/1 mm criteria was only 70.8% for the comparison of dose distribution between planning CT and original sCT. The mean dose difference between the planning CT and the original sCT were -1.2% for PTV D₉₅ and -1.7% for PTV D_max, while the mean dose difference was within 0.7 Gy for all relevant OARs. After applying the modifications on the sCT, the average gamma passing rate was increased to 92.2%. Mean dose difference in PTV D₉₅ and D_max were reduced to -0.1% and -0.3% respectively. The mean dose difference was within 0.2 Gy for all OAR structures and no statistically significant difference were found.

Conclusions: The modified-sCT demonstrated improved dosimetric agreement with the planning CT. These results indicated the overall dosimetric accuracy and practicality of this improved MR-based treatment planning method.

Keywords: Brain cancer; MR-only radiotherapy; Synthetic CT.

MeSH terms

Brain Neoplasms* / diagnostic imaging
Brain Neoplasms* / radiotherapy
Humans
Magnetic Resonance Imaging
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
Radiotherapy, Intensity-Modulated*